| Lipid Composition for FDC-321 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 3.54 | 4.5 | 90 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.41 | 0.5 | 10 |
| Total | 3.95 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-322 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 3.15 | 4 | 80 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.81 | 1 | 20 |
| Total | 3.96 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-323 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 2.75 | 3.5 | 70 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 1.22 | 1.5 | 30 |
| Total | 3.97 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-324 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 2.36 | 3 | 60 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 1.62 | 2 | 40 |
| Total | 3.98 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-325 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 1.97 | 2.5 | 50 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 2.03 | 2.5 | 50 |
| Total | 4.00 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-326 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 1.57 | 2 | 40 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 2.43 | 3 | 60 |
| Total | 4.00 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-327 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 1.18 | 1.5 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 2.84 | 3.5 | 70 |
| Total | 4.02 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-328 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.79 | 1 | 20 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 3.24 | 4 | 80 |
| Total | 4.03 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-329 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.40 | 0.5 | 10 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 3.65 | 4.5 | 90 |
| Total | 4.05 mg/ml | 5 mM | 100 |
| Lipid Composition for FDC-330 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 4.05 | 5 | 100 |
